ATE255450T1 - Matrix für iontophorese - Google Patents
Matrix für iontophoreseInfo
- Publication number
- ATE255450T1 ATE255450T1 AT96108896T AT96108896T ATE255450T1 AT E255450 T1 ATE255450 T1 AT E255450T1 AT 96108896 T AT96108896 T AT 96108896T AT 96108896 T AT96108896 T AT 96108896T AT E255450 T1 ATE255450 T1 AT E255450T1
- Authority
- AT
- Austria
- Prior art keywords
- drug
- humectant
- weight
- iontophoresis
- proline
- Prior art date
Links
- 239000011159 matrix material Substances 0.000 title abstract 2
- 239000003814 drug Substances 0.000 abstract 4
- 229940079593 drug Drugs 0.000 abstract 4
- 239000003906 humectant Substances 0.000 abstract 3
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 abstract 2
- ONIBWKKTOPOVIA-UHFFFAOYSA-N Proline Natural products OC(=O)C1CCCN1 ONIBWKKTOPOVIA-UHFFFAOYSA-N 0.000 abstract 2
- 150000001413 amino acids Chemical class 0.000 abstract 2
- 150000005846 sugar alcohols Polymers 0.000 abstract 2
- 229920002683 Glycosaminoglycan Polymers 0.000 abstract 1
- ONIBWKKTOPOVIA-BYPYZUCNSA-N L-Proline Chemical compound OC(=O)[C@@H]1CCCN1 ONIBWKKTOPOVIA-BYPYZUCNSA-N 0.000 abstract 1
- 230000002378 acidificating effect Effects 0.000 abstract 1
- 150000001875 compounds Chemical class 0.000 abstract 1
- 238000004090 dissolution Methods 0.000 abstract 1
- 235000011187 glycerol Nutrition 0.000 abstract 1
- 239000007788 liquid Substances 0.000 abstract 1
- 108090000765 processed proteins & peptides Proteins 0.000 abstract 1
- 108090000623 proteins and genes Proteins 0.000 abstract 1
- 102000004169 proteins and genes Human genes 0.000 abstract 1
- 150000003839 salts Chemical class 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61N—ELECTROTHERAPY; MAGNETOTHERAPY; RADIATION THERAPY; ULTRASOUND THERAPY
- A61N1/00—Electrotherapy; Circuits therefor
- A61N1/18—Applying electric currents by contact electrodes
- A61N1/20—Applying electric currents by contact electrodes continuous direct currents
- A61N1/30—Apparatus for iontophoresis, i.e. transfer of media in ionic state by an electromotoric force into the body, or cataphoresis
Landscapes
- Health & Medical Sciences (AREA)
- Engineering & Computer Science (AREA)
- Biomedical Technology (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Radiology & Medical Imaging (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Preparation (AREA)
- Steroid Compounds (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP14298395 | 1995-06-09 | ||
| JP20190295 | 1995-08-08 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| ATE255450T1 true ATE255450T1 (de) | 2003-12-15 |
Family
ID=26474826
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| AT96108896T ATE255450T1 (de) | 1995-06-09 | 1996-06-04 | Matrix für iontophorese |
Country Status (5)
| Country | Link |
|---|---|
| US (2) | US5993848A (de) |
| EP (1) | EP0747092B1 (de) |
| AT (1) | ATE255450T1 (de) |
| CA (1) | CA2178445A1 (de) |
| DE (1) | DE69630918T2 (de) |
Families Citing this family (30)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CA2208332A1 (en) * | 1996-06-20 | 1997-12-20 | Hisamitsu Pharmaceuticals Co., Inc. | Drug administration composition for iontophoresis |
| EP0813887A3 (de) * | 1996-06-20 | 1999-11-03 | Hisamitsu Pharmaceutical Co. Inc. | Iontophoretische Vorrichtung |
| EP0922467A3 (de) | 1997-12-12 | 2000-05-24 | Takeda Chemical Industries, Ltd. | Iontophoretische Verabreichung von Medikamenten |
| JP4154016B2 (ja) * | 1997-12-30 | 2008-09-24 | 久光製薬株式会社 | イオントフォレーシス装置およびその組み立て方法 |
| JP4154017B2 (ja) * | 1997-12-30 | 2008-09-24 | 久光製薬株式会社 | イオントフォレーシス装置および薬物ユニット |
| CA2269050A1 (en) | 1998-04-14 | 1999-10-14 | Shigeo Yanai | Method for transdermal administration of gp iib/iiia antagonist |
| US7197359B1 (en) * | 1999-10-14 | 2007-03-27 | Pola Chemical Industries Inc. | Compositions for electroporation |
| EP1222932B1 (de) | 1999-10-14 | 2007-02-21 | Pola Chemical Industries Inc. | Zusammensetzungen für die elektroporation |
| AU2001277908A1 (en) * | 2000-07-18 | 2002-01-30 | Cornell Research Foundation Inc. | Medicinal uses of mu-opioid receptor agonists |
| US6801804B2 (en) | 2002-05-03 | 2004-10-05 | Aciont, Inc. | Device and method for monitoring and controlling electrical resistance at a tissue site undergoing iontophoresis |
| US7099713B2 (en) | 2002-06-28 | 2006-08-29 | Battelle Memorial Institute | Skin conduction and transport systems |
| CN102784383B (zh) * | 2003-02-04 | 2014-09-17 | 科内尔研究基金会 | 用于防止线粒体通透性改变的方法 |
| DK2604286T3 (en) | 2003-05-01 | 2014-12-08 | Cornell Res Foundation Inc | Method and carrier complex for delivering molecules to cells |
| BRPI0507053A (pt) * | 2004-01-23 | 2007-06-12 | Cornell Res Foundation Inc | métodos para reduzir o dano oxidativo em um mamìfero em necessidade deste, em um órgão removido de um mamìfero e uma célula em necessidade deste |
| JP4615929B2 (ja) * | 2004-08-11 | 2011-01-19 | 久光製薬株式会社 | イオントフォレーシス装置 |
| DE102005024040A1 (de) * | 2005-05-25 | 2006-12-14 | Rovi Gmbh & Co. Kosmetische Rohstoffe Kg | Kosmetisches oder therapeutisches Kombinationspräparat mit Theanin |
| JP2008543359A (ja) * | 2005-06-10 | 2008-12-04 | トランスファーマ メディカル，リミティド | 経皮投薬用のパッチ |
| AU2006292352B2 (en) * | 2005-09-16 | 2012-02-09 | Cornell Research Foundation, Inc. | Methods for reducing CD36 expression |
| CA2696227A1 (en) * | 2007-10-17 | 2009-04-23 | Transpharma Medical Ltd. | Dissolution rate verification |
| CA2704164A1 (en) | 2007-10-29 | 2009-05-07 | Transpharma Medical Ltd. | Vertical patch drying |
| EP2712620A1 (de) | 2008-02-07 | 2014-04-02 | Cornell University | Verfahren zur Vorbeugung oder Behandlung von Insulinresistenz |
| WO2009108695A2 (en) | 2008-02-26 | 2009-09-03 | Cornell University | Methods for prevention and treatment of acute renal injury |
| US20110223204A1 (en) * | 2008-06-04 | 2011-09-15 | Bradford J Duft | Treatment of pain with gap junction modulation compounds |
| JP2012521355A (ja) | 2009-03-20 | 2012-09-13 | ザ ジェネラル ホスピタル コーポレイション ディー ビー エイ マサチューセッツ ジェネラル ホスピタル | 熱傷及び二次性合併症の予防及び治療方法 |
| DK2464371T3 (en) * | 2009-08-12 | 2016-06-27 | Univ Cornell | Methods for preventing or treating metabolic syndrome |
| PT2470191E (pt) | 2009-08-24 | 2014-06-12 | Stealth Peptides Int Inc | Métodos e composições para prevenção ou tratamento de doenças oftálmicas |
| EP2485749A4 (de) | 2009-10-05 | 2013-07-24 | Univ Cornell | Verfahren zur prävention und behandlung von herzinsuffizienz |
| CN103918096B (zh) | 2011-10-28 | 2018-09-28 | 印度马德拉斯理工学院 | 压电器件及其制备和使用方法 |
| CA2868534A1 (en) | 2012-03-27 | 2013-10-03 | Coda Therapeutics, Inc. | Compositions and treatments based on cadherin modulation |
| EP2849774A4 (de) | 2012-05-18 | 2015-11-25 | Otago Innovation Ltd | Kombinationsbehandlungen und zusammensetzungen zur wundheilung |
Family Cites Families (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4593053A (en) * | 1984-12-07 | 1986-06-03 | Medtronic, Inc. | Hydrophilic pressure sensitive biomedical adhesive composition |
| IE60941B1 (en) * | 1986-07-10 | 1994-09-07 | Elan Transdermal Ltd | Transdermal drug delivery device |
| US5250022A (en) * | 1990-09-25 | 1993-10-05 | Rutgers, The State University Of New Jersey | Iontotherapeutic devices, reservoir electrode devices therefore, process and unit dose |
| US5612347A (en) * | 1988-03-28 | 1997-03-18 | Janssen Pharmaceutica N.V. | Agents for preserving or restoring the soundness of the skin |
| AU624481B2 (en) * | 1989-02-06 | 1992-06-11 | Hisamitsu Pharmaceutical Co. Inc. | Interface for iontophoresis |
| JPH0532696A (ja) * | 1990-09-28 | 1993-02-09 | Takeda Chem Ind Ltd | 副甲状腺ホルモン誘導体 |
| US5158537A (en) * | 1990-10-29 | 1992-10-27 | Alza Corporation | Iontophoretic delivery device and method of hydrating same |
| EP0612253A4 (de) * | 1991-11-12 | 1995-08-09 | Nepera Inc | Anklebenok hydrogele mit verlängerter lebensdauer und verfahren zu ihrer herstellung. |
| DE69320378T2 (de) * | 1992-01-21 | 1999-04-29 | Macrochem Corp | Iontophoretische verbesserte Verabreichung von Medikamenten |
| DE69326461T2 (de) * | 1992-06-11 | 2000-05-04 | Theratech Inc., Salt Lake City | Verwendung von glyzerin zur dämpfung der transdermalen arzneimittelverabreichung |
| JPH0616535A (ja) * | 1992-07-03 | 1994-01-25 | Japan Tobacco Inc | イオントフォレーゼ用インターフェイス |
| JPH0616538A (ja) * | 1992-07-03 | 1994-01-25 | Japan Tobacco Inc | イオントフォレーゼのための薬物吸収用液組成物 |
| EP0651993B1 (de) * | 1992-07-23 | 2002-10-09 | Hisamitsu Pharmaceutical Co., Inc. | Perkutan verabreichbare basiszusammensetzung und daraus hergestellte zusammensetzung |
| EP0643981B1 (de) * | 1993-09-22 | 2002-01-09 | Hisamitsu Pharmaceutical Co., Inc. | Iontophoresematrix |
| US5472958A (en) * | 1994-08-29 | 1995-12-05 | Abbott Laboratories | 2-((nitro)phenoxymethyl) heterocyclic compounds that enhance cognitive function |
-
1996
- 1996-06-04 AT AT96108896T patent/ATE255450T1/de not_active IP Right Cessation
- 1996-06-04 DE DE69630918T patent/DE69630918T2/de not_active Expired - Fee Related
- 1996-06-04 EP EP96108896A patent/EP0747092B1/de not_active Expired - Lifetime
- 1996-06-06 CA CA002178445A patent/CA2178445A1/en not_active Abandoned
- 1996-06-06 US US08/659,372 patent/US5993848A/en not_active Expired - Lifetime
-
1998
- 1998-08-21 US US09/137,744 patent/US6248349B1/en not_active Expired - Lifetime
Also Published As
| Publication number | Publication date |
|---|---|
| EP0747092A3 (de) | 1998-04-08 |
| US6248349B1 (en) | 2001-06-19 |
| DE69630918D1 (de) | 2004-01-15 |
| DE69630918T2 (de) | 2004-10-28 |
| EP0747092B1 (de) | 2003-12-03 |
| CA2178445A1 (en) | 1996-12-10 |
| US5993848A (en) | 1999-11-30 |
| EP0747092A2 (de) | 1996-12-11 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| ATE255450T1 (de) | Matrix für iontophorese | |
| ES2526707T3 (es) | Purificación y estabilización de péptidos y proteínas en agentes farmacéuticos | |
| DE69329367D1 (de) | Wachstumshormon-enthaltendeproteinformulierung | |
| DE69434418D1 (de) | Orale Dareichungsform | |
| CA2275890A1 (en) | Stable liquid interferon formulations | |
| ATE442851T1 (de) | 1-deoxy-galactonojirimycin-derivate zur vewendung bei der behandlung von lysosomalen speicherkrankheiten mittels steigerung der lysosomalen alpha galactosidase a | |
| ATE305775T1 (de) | Tulobuterol enthaltendes präparat für perkutane absorption | |
| PT1017413E (pt) | Formulacoes liquidas de interferao (beta) | |
| CA2326662A1 (en) | Therapeutic system which can be moisture-activated | |
| DE69417397D1 (de) | Lösung, die igf-1 enthält | |
| US6399566B1 (en) | Topical preparation for introducing insulin in living organisms | |
| ATE61522T1 (de) | Pharmazeutische zubereitung zur behandlung von tinea pedis. | |
| ATE226832T1 (de) | Mittel zur arzneistoffverabreichung durch iontophorese | |
| ATE12649T1 (de) | Optisch aktives dipeptide, seine pharmazeutisch vertraeglichen salze, verfahren zur herstellung und diese enthaltende pharmazeutische praeparate. | |
| Shen et al. | Cell Reproduction | |
| OA12322A (en) | Topical pharmaceutical preparation. | |
| TH19245A (th) | วิธีป้องกันการสลายของโปรตีนซี | |
| CA2153787A1 (en) | Solution containing igf-1 | |
| TH25313A (th) | องค์ประกอบทางเภสัชที่ออกฤทธิ์ผ่านทางผิวหนังที่มีกรด 5-แอมิโนเลฟวูลินิกประกอบอยู่ |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| RER | Ceased as to paragraph 5 lit. 3 law introducing patent treaties |